You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中珠醫療(600568.SH)擬1.11億元轉讓廣州新泰達70%股權
格隆匯 01-08 18:07

格隆匯1月8日丨中珠醫療(600568.SH)公佈,為儘早收回投資成本,降低未來不確定性風險,同時在充分考慮新藥研發投入大、週期長、風險高、以及市場上已存在同類型產品,未來市場競爭優勢有限等因素的基礎上,公司於2020年1月8日與廣州灌漿島生物科技有限公司(以下簡稱“廣州灌漿島”)簽署附生效條件的《股權轉讓協議》,擬以總價人民幣1.11億元的價格轉讓公司所持廣州新泰達生物科技有限公司(以下簡稱“廣州新泰達”或“交易標的”)70%股權。

轉讓完成後,公司將不再持有廣州新泰達的股權。廣州新泰達其他股東黃文林已出具放棄優先購買權的聲明。經公司財務部門初步測算,本次轉讓廣州新泰達70%股權交易完成後,公司將獲得税前收益約5813萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account